Cox Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $861K | Sell |
6,698
-57
| -0.8% | -$6.67K | 0.48% | 58 |
|
|
2026
Q1 | $813K | Hold |
6,755
| – | – | 0.54% | 52 |
|
|
2025
Q4 | $731K | Sell |
6,755
-1
| -0% | -$94 | 0.45% | 49 |
|
|
2025
Q3 | $567K | Buy |
6,756
+36
| +0.5% | +$2.96K | 0.37% | 50 |
|
|
2025
Q2 | $532K | Sell |
6,720
-25
| -0.4% | -$1.99K | 0.36% | 48 |
|
|
2025
Q1 | $605K | Sell |
6,745
-11,592
| -63% | -$1.08M | 0.44% | 45 |
|
|
2024
Q4 | $1.82M | Sell |
18,337
-52
| -0.3% | -$5.36K | 1.17% | 35 |
|
|
2024
Q3 | $2.09M | Sell |
18,389
-180
| -1% | -$21.4K | 1.25% | 35 |
|
|
2024
Q2 | $2.3M | Sell |
18,569
-1,019
| -5% | -$131K | 1.39% | 31 |
|
|
2024
Q1 | $2.58M | Sell |
19,588
-868
| -4% | -$107K | 1.59% | 29 |
|
|
2023
Q4 | $2.23M | Sell |
20,456
-17,580
| -46% | -$1.82M | 1.46% | 28 |
|
|
2023
Q3 | $3.92M | Buy |
38,036
+2,089
| +6% | +$225K | 2.75% | 6 |
|
|
2023
Q2 | $4.15M | Sell |
35,947
-1,242
| -3% | -$141K | 3.06% | 4 |
|
|
2023
Q1 | $3.96M | Buy |
37,189
+10
| +0% | +$1.08K | 2.86% | 4 |
|
|
2022
Q4 | $4.12M | Sell |
37,179
-1,133
| -3% | -$116K | 2.68% | 4 |
|
|
2022
Q3 | $3.3M | Buy |
38,312
+268
| +0.7% | +$23.9K | 2.4% | 9 |
|
|
2022
Q2 | $3.47M | Sell |
38,044
-1,254
| -3% | -$111K | 2.37% | 7 |
|
|
2022
Q1 | $3.22M | Buy |
39,298
+26
| +0.1% | +$2.05K | 2.03% | 14 |
|
|
2021
Q4 | $3.01M | Sell |
39,272
-6,819
| -15% | -$543K | 1.78% | 19 |
|
|
2021
Q3 | $3.46M | Buy |
46,091
+946
| +2% | +$71.9K | 2.33% | 9 |
|
|
2021
Q2 | $3.51M | Buy |
45,145
+28
| +0.1% | +$2.08K | 2.35% | 8 |
|
|
2021
Q1 | $3.32M | Buy |
45,117
+185
| +0.4% | +$13.6K | 2.3% | 8 |
|
|
2020
Q4 | $3.51M | Buy |
44,932
+887
| +2% | +$67.8K | 2.67% | 4 |
|
|
2020
Q3 | $3.49M | Buy |
44,045
+226
| +0.5% | +$17.7K | 3.08% | 3 |
|
|
2020
Q2 | $3.23M | Buy |
43,819
+21,222
| +94% | +$1.6M | 3.19% | 3 |
|
|
2020
Q1 | $1.96M | Hold |
22,597
| – | – | 1.71% | 22 |
|
|
2019
Q4 | $1.96M | Buy |
22,597
+373
| +2% | +$30.6K | 1.78% | 22 |
|
|
2019
Q3 | $1.78M | Buy |
22,224
+8,941
| +67% | +$717K | 1.74% | 24 |
|
|
2019
Q2 | $1.06M | Hold |
13,283
| – | – | 1.08% | 39 |
|
|
2019
Q1 | $1.05M | Sell |
13,283
-2,332
| -15% | -$174K | 1.14% | 41 |
|
|
2018
Q4 | $1.09M | Buy |
15,615
+6,442
| +70% | +$455K | 1.28% | 38 |
|
|
2018
Q3 | $621K | Hold |
9,173
| – | – | 0.66% | 51 |
|
|
2018
Q2 | $531K | Buy |
+9,173
| New | +$518K | 0.64% | 58 |
|
Other funds holding MRK
ECSS
Cox Capital Management's MRK Position: Q2 2026 in Review
Cox Capital Management reduced its Merck (MRK) stake by 0.84% in Q2 2026, selling an estimated $6.67K and leaving 6,698 shares worth $861K. The position accounts for 0.48% of the portfolio, ranked #58.
Cox Capital Management first reported a position in MRK in Q2 2018 and has held it in 33 quarters since. The position peaked at $4.15M in Q2 2023. 1,784 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Cox Capital Management held 6,698 shares of Merck worth $861K as of Q2 2026.
- Cox Capital Management sold 57 Merck shares in Q2 2026, an estimated $6.67K.
- Merck made up 0.48% of Cox Capital Management's portfolio in Q2 2026, its #58 holding.
- Cox Capital Management first reported a position in Merck in Q2 2018 and has held it in 33 quarters since.
- Cox Capital Management's Merck position peaked at $4.15M in Q2 2023.
- 1,784 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Cox Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.